ZBP1-driven cell death in severe influenza
Trends in Microbiology · 2025-05 · 33 (5) · 521-532
DOI: 10.1016/j.tim.2024.12.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Microbiology, 2025-05. Verfasst von David F Boyd und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, USA. Electronic address: dfboyd@ucsc.edu. Hauptthemen laut MEDLINE: Influenza, Human, RNA-Binding Proteins, Influenza A virus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, USA. Electronic address: dfboyd@ucsc.edu.
- Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, USA.
- Center for Immunology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: Siddharth.balachandran@fccc.edu.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Cancer Research Institute
- Tufts University
- University of Houston
Zitieren
APA
Boyd, D. F., Jordan, S. V., & Balachandran, S. (2025). ZBP1-driven cell death in severe influenza. Trends in Microbiology, 33(5), 521-532. https://doi.org/10.1016/j.tim.2024.12.008
Vancouver
Boyd DF, Jordan SV, Balachandran S. ZBP1-driven cell death in severe influenza. Trends in Microbiology. 2025;33(5):521-532. doi:10.1016/j.tim.2024.12.008
BibTeX
@article{Boyd2025,
author = {Boyd, David F and Jordan, Summer Vaughn and Balachandran, Siddharth},
title = {ZBP1-driven cell death in severe influenza},
journal = {Trends in Microbiology},
year = {2025},
volume = {33},
number = {5},
pages = {521--532},
doi = {10.1016/j.tim.2024.12.008}
}
EUVIMED